188 related articles for article (PubMed ID: 8010321)
21. High-performance liquid chromatographic method optimization for ondansetron assay in extemporaneous topical gel and in marketed products.
Quamrun M; Mamoon R; Nasheed S; Randy M
Int J Pharm Compd; 2014; 18(6):520-5. PubMed ID: 25906631
[TBL] [Abstract][Full Text] [Related]
22. Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions.
Fleming RA; Olsen DJ; Savage PD; Fox JL
Am J Health Syst Pharm; 1995 Mar; 52(5):514-6. PubMed ID: 7606557
[No Abstract] [Full Text] [Related]
23. Stability of sulfadiazine oral liquids prepared from tablets and powder.
Pathmanathan U; Halgrain D; Chiadmi F; Schlatter J; Vermerie N
J Pharm Pharm Sci; 2004 Apr; 7(1):84-7. PubMed ID: 15144740
[TBL] [Abstract][Full Text] [Related]
24. Quantitative determination of ondansetron in human plasma by enantioselective liquid chromatography-tandem mass spectrometry.
Liu K; Dai X; Zhong D; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 864(1-2):129-36. PubMed ID: 18299256
[TBL] [Abstract][Full Text] [Related]
25. Stability of reserpine injections and tablets submitted by U.S. hospitals.
Coffman HD; Crabbs WC; Kolinski RE; Page DP
Am J Hosp Pharm; 1986 Jan; 43(1):103-9. PubMed ID: 3953579
[TBL] [Abstract][Full Text] [Related]
26. Stability of ondansetron hydrochloride injection in various beverages.
Yamreudeewong W; Danthi SN; Hill RA; Fox JL
Am J Health Syst Pharm; 1995 Sep; 52(18):2011-4. PubMed ID: 8528869
[TBL] [Abstract][Full Text] [Related]
27. Stability of an extemporaneously compounded baclofen oral liquid.
Johnson CE; Hart SM
Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
[TBL] [Abstract][Full Text] [Related]
28. Non-enzymic browning in solid-dosage forms: lactose-induced discoloration of neomycin tablets.
Hammouda Y; Salakawy SA
Pharmazie; 1971 Oct; 26(10):636-40. PubMed ID: 5149136
[No Abstract] [Full Text] [Related]
29. Physical and chemical stability of pemetrexed in infusion solutions.
Zhang Y; Trissel LA
Ann Pharmacother; 2006 Jun; 40(6):1082-5. PubMed ID: 16720706
[TBL] [Abstract][Full Text] [Related]
30. Stability of pilocarpine hydrochloride and pilocarpine nitrate ophthalmic solutions submitted by U.S. hospitals.
Kreienbaum MA; Page DP
Am J Hosp Pharm; 1986 Jan; 43(1):109-17. PubMed ID: 3953580
[TBL] [Abstract][Full Text] [Related]
31. Off-label antibiotic preparation.
Dobrinas M; Fleury-Souverain S; Bonnabry P; Sadeghipour F
Ophthalmology; 2007 Nov; 114(11):2095. PubMed ID: 17980744
[No Abstract] [Full Text] [Related]
32. Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs.
Stiles ML; Allen LV; Prince SJ; Holland JS
Am J Hosp Pharm; 1994 Feb; 51(4):514-7. PubMed ID: 8017420
[No Abstract] [Full Text] [Related]
33. Stability of cyanocobalamin in sugar-coated tablets.
Ohmori S; Kataoka M; Koyama H
Int J Pharm; 2007 Jun; 337(1-2):161-8. PubMed ID: 17300886
[TBL] [Abstract][Full Text] [Related]
34. Studies on stability testing in pharmaceutical formulation.
Lundgren P
Acta Pharm Suec; 1971 Jun; 8(3):169-92. PubMed ID: 5314840
[No Abstract] [Full Text] [Related]
35. Storage stability of mixed hyperalimentation solutions.
Rowlands DA; Wilkinson WR; Yoshimura N
Am J Hosp Pharm; 1973 May; 30(5):436-8. PubMed ID: 4574336
[No Abstract] [Full Text] [Related]
36. The compatibility and stability of midazolam and dexamethasone in infusion solutions.
Good PD; Schneider JJ; Ravenscroft PJ
J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775
[TBL] [Abstract][Full Text] [Related]
37. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
[TBL] [Abstract][Full Text] [Related]
38. Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions.
Ferreira AO; Polonini HC; Loures da Silva S; Cerqueira de Melo VA; de Andrade L; Brandão MAF
Int J Pharm Compd; 2017; 21(3):255-263. PubMed ID: 28557789
[TBL] [Abstract][Full Text] [Related]
39. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 1. Effect of binders.
Asker A; el-Nakeeb M; Motawi M; el-Gindy N
Pharmazie; 1972 Sep; 27(9):600-3. PubMed ID: 5086358
[No Abstract] [Full Text] [Related]
40. Ondansetron: design and development of oral pharmaceutical suspensions.
Gallardo Lara V; Gallardo ML; Morales Hernandez ME; Ruiz Martinez MA
Pharmazie; 2009 Feb; 64(2):90-3. PubMed ID: 19320280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
